For additional information call: Grants provided to “New Investigators” to continue vital work. The Leukemia Research Foundation (LRF) is proud to announce the distribution of $990,810 in funding for blood cancer research at institutions all over the United States. The Foundation offers individual, one-year grants of up to $100,000. The list of grantees and institutions funded is as follows: •Zaneta Nikolovska-Coleska, Ph.D. - University of Michigan •Claire Edwards, Ph.D. - Vanderbilt University “Each year since its founding in 1946, the Leukemia Research Foundation has made good on its primary tenet to fund research into the cause of a cure for leukemia, lymphoma and MDS, through its Hollis Brownstein Research Grant Program,” said LRF Executive Director Kevin Radelet. “The $100,000 grants we’ve provided support New Investigators, scientists who are within seven years of their first professional appointment. Support for New Investigators has been identified as a key niche that has, in the past, been a difficult one for major funders to accommodate,” Radelet said. Dozens of proposals from institutions around the world were received by the LRF. The proposals were organized by specialty then matched to the expertise of the Foundation’s Medical Advisory Board (M.A.B.) by Board Chairperson Michael Thirman, M.D., director of leukemia biology at University of Chicago. Each proposal was thoroughly evaluated and scored. The full MAB membership, senior scientists from every area of hematologic malignancy research, discussed each project in person that scored in the top half of the preliminary critique. Final recommendations were forwarded to the LRF for funding. For more information about the Leukemia Research Foundation and the newly-funded research projects and past recipients, click here, or call 847-424-0600.
|
|
